Selonsertib in Adults With Pulmonary Arterial Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT02234141
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 151 participants
- Sponsor
- Registry
-
NCT02234141 -
2014-002131-34
-
- Other papers using this trial's data
- Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, France, Germany, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02234141. Randomized; double masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2016-04 (actual). Results posted on 2019-04-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Selonsertib in Adults With Pulmonary Arterial Hypertension
- Acronym
- ARROW
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Selonsertib
- Lead sponsor
- Gilead Sciences
Record details
- Record id
cardio:ct-nct02234141- Content hash
b018ed40e66612b22484d99c98480121859d1b51122e5c425a1d604827d01185